Rosuvastatin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5397 publications

Dose-dependent effects of rosuvastatin in deep vein thrombosis: a retrospective cohort study.

Dose-dependent effects of rosuvastatin in deep vein thrombosis: a retrospective cohort study.

Journal: International angiology : a journal of the International Union of Angiology

Published: June 15, 2026

Locally delivered simvastatin and rosuvastatin in the treatment of chronic periodontitis: A systematic review and meta-analysis.

Locally delivered simvastatin and rosuvastatin in the treatment of chronic periodontitis: A systematic review and meta-analysis.

Journal: American journal of dentistry

Published: June 05, 2026

Drugs for hypercholesterolemia.

Drugs for hypercholesterolemia.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Comparison chart: Statins.

Comparison chart: Statins.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.

Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial.

Journal: BMJ open

Published: May 27, 2026

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Journal: Journal of primary care & community health

Published: May 22, 2026

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.

Journal: Circulation

Published: May 15, 2026

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

Journal: Circulation

Published: May 15, 2026

Reassessment of Long-Term Guideline-Directed Therapy for Peripheral Arterial Occlusive Disease in Primary Care.

Reassessment of Long-Term Guideline-Directed Therapy for Peripheral Arterial Occlusive Disease in Primary Care.

Journal: Cureus

Published: May 09, 2026

New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9.

New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: May 08, 2026

Rosuvastatin Attenuates Pulmonary Damage in Rats with Cecal Ligation and Puncture-Induced Sepsis.

Rosuvastatin Attenuates Pulmonary Damage in Rats with Cecal Ligation and Puncture-Induced Sepsis.

Journal: Journal of clinical medicine

Published: April 28, 2026

Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment.

Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment.

Journal: Journal of the American Heart Association

Published: April 22, 2026

Showing 1-12 of 5,397

Last Updated: 06/30/2026